Home Cart Sign in  
Chemical Structure| 2380274-50-8 Chemical Structure| 2380274-50-8

Structure of AU-15330
CAS No.: 2380274-50-8

Chemical Structure| 2380274-50-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

AU-15330 is a PROTAC degrader targeting the SWI/SNF ATPase subunits SMARCA2 and SMARCA4. It is effective in prostate cancer models and can be used in combination with AR antagonists, showing anti-tumor potential.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of AU-15330

CAS No. :2380274-50-8
Formula : C39H49N9O5S
M.W : 755.92
SMILES Code : C([C@@H](NC(CN1CCN(CC1)C=2C=C(N=NC2N)C3=C(O)C=CC=C3)=O)[C@@](C)(C)C)(=O)N4[C@H](C(N[C@@H](C)C5=CC=C(C=C5)C6=C(C)N=CS6)=O)C[C@@H](O)C4
MDL No. :N/A

Safety of AU-15330

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of AU-15330

epigenetics

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
H3WT cell lines (SF188, SJGBM2) 1 μM 24 h Evaluate the effect of AU-15330 on SMARCA4, SMARCA2, and PBRM1 protein levels, showing reduced levels of these proteins. Proc Natl Acad Sci U S A. 2023 May 2;120(18):e2221175120
22Rv1 cells 1 µM Study the degradation effects of AU-15330 on SMARCA4, SMARCA2, and PBRM1 Proc Natl Acad Sci U S A. 2024 Apr 9;121(15):e2322563121.
22RV1 cells 1 μM 24h Evaluate the degradation effect of AU-15330 on SMARCA2 and SMARCA4, showing significant degradation. Nature. 2022 Jan;601(7893):434-439
LNCaP cells 1 μM 24h Evaluate the effect of AU-15330 on cell growth, showing significant growth inhibition and apoptosis induction. Nature. 2022 Jan;601(7893):434-439
VCaP cells 1 μM 4h Evaluate the degradation effect of AU-15330 on SMARCA2, SMARCA4, and PBRM1, showing time-dependent degradation. Nature. 2022 Jan;601(7893):434-439

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice CRPC VCaP xenograft model Intravenous injection 60 mg/kg 3 times per week for 4 weeks Evaluate the therapeutic effects of AU-15330 in CRPC model Proc Natl Acad Sci U S A. 2024 Apr 9;121(15):e2322563121.
SCID mice VCaP-CRPC xenograft model Intravenous injection 60 mg/kg 3 days per week for 5 weeks Evaluate the inhibitory effect of AU-15330 on tumor growth, showing significant tumor growth inhibition and partial tumor regression. Nature. 2022 Jan;601(7893):434-439

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.32mL

0.26mL

0.13mL

6.61mL

1.32mL

0.66mL

13.23mL

2.65mL

1.32mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories